ArticleExperimental and therapeutic medicine2025

Imiquimod promotes Th1 and Th17 responses via NF-κB-driven IL-12 and IL-6 production in an

Yerim Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.